GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
Glucagon-like peptide-1 (GLP-1) reduces cardiovascular events in diabetic patients; however, its counter-protective effects have also been suggested in patients with heart failure and the clear explanation for...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Aya Shiraki, Jun-ichi Oyama, Toshiyuki Nishikido and Koichi Node Tags: Original investigation Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Dilated Cardiomyopathy | Endocrinology | Heart | Heart Failure | Victoza